Comparison between GSM Foils IPO and Quest Laboratories IPO.
IPO Details
GSM Foils IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Quest Laboratories IPO is a SME Bookbuilding proposed to list at NSE SME.
Issue Size and Price
The total issue size of GSM Foils IPO is up to ₹10.44 Cr whereas the issue size of the Quest Laboratories IPO is up to ₹40.95 Cr. The final issue price of GSM Foils IPO is ₹32.00 per share and of Quest Laboratories IPO is ₹97.00 per share.
IPO Timetable
GSM Foils IPO opens on May 24, 2024, while Quest Laboratories IPO opens on May 15, 2024. The closing date of GSM Foils IPO and Quest Laboratories IPO is May 28, 2024, and May 17, 2024, respectively.
| | GSM Foils IPO | Quest Laboratories IPO |
|---|
| Anchor Bid Date | | May 14, 2024 |
| Issue Open | May 24, 2024 | May 15, 2024 |
| Issue Close | May 28, 2024 | May 17, 2024 |
| Basis Of Allotment (Tentative) | May 29, 2024 | May 21, 2024 |
| Initiation of Refunds (Tentative) | May 30, 2024 | May 22, 2024 |
| Credit of Share (Tentative) | May 30, 2024 | May 22, 2024 |
| Listing date (Tentative) | May 31, 2024 | May 23, 2024 |
| Anchor Lockin End date 1 | | Jun 20, 2024 |
| Anchor Lockin End date 2 | | Aug 19, 2024 |
Financials & KPIs
GSM Foils IPO P/E ratio is 20.98, as compared to Quest Laboratories IPO P/E ratio of 23.03.
Shares Offered
In the GSM Foils IPO Retail Individual Investors (RII) are offered 16,32,000 shares while in Quest Laboratories IPO retail investors are offered 16,32,000 shares. Qualified Institutional Buyers (QIB) are offered in GSM Foils IPO and 8,31,600 shares in Quest Laboratories IPO.
| | GSM Foils IPO | Quest Laboratories IPO |
|---|
| Anchor Investor Reservation | | 12,36,000 shares |
| Market Maker Reservation | 1,76,000 shares | 2,28,000 shares |
| QIB | | 8,31,600 shares |
| NII | 16,32,000 shares | 6,55,200 shares |
| RII | 16,32,000 shares | 14,98,800 shares |
| Employee | | |
| Others | | |
| Total | 32,64,000 shares | 42,21,600 shares |
Bids Received (Subscription)
GSM Foils IPO subscribed 253.31x in total, whereas Quest Laboratories IPO subscribed 60.30x.
